Estrogen receptor, progesterone receptor, interleukin-6 and interleukin-8 are variable in breast cancer and benign stem/progenitor cell populations

BACKGROUND: Estrogen receptor positive breast cancers have high recurrence rates despite tamoxifen therapy. Breast cancer stem/progenitor cells (BCSCs) initiate tumors, but expression of estrogen (ER) or progesterone receptors (PR) and response to tamoxifen is unknown. Interleukin-6 (IL-6) and inter...

Descripción completa

Detalles Bibliográficos
Autores principales: Schillace, Robynn V, Skinner, Amy M, Pommier, Rodney F, O’Neill, Steven, Muller, Patrick J, Naik, Arpana M, Hansen, Juliana E, Pommier, SuEllen J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4190475/
https://www.ncbi.nlm.nih.gov/pubmed/25269750
http://dx.doi.org/10.1186/1471-2407-14-733

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4190475/
https://www.ncbi.nlm.nih.gov/pubmed/25269750
http://dx.doi.org/10.1186/1471-2407-14-733

Ejemplares similares